Abstract
In 1842, Erichsen (1842) observed ‘tremulation of the ventricles’ within 2 min of occlusion by ligation of the main coronary artery of rabbits and dogs. In the subsequent 140 years, the possible factors which determined the onset of ventricular fibrillation following regional ischaemia have been studied in detail. These studies have acquired enhanced clinical relevance within the last 20 years because a large number of deaths in patients with coronary artery disease are sudden, and have been attributed to ‘tremulation of the ventricles’ or ventricular fibrillation. Sudden death is commonest in patients with extensive coronary artery disease who smoke cigarettes. It is postulated that a transient episode occurs which suddenly alters the electrical stability of the heart, leading to lethal ventricular arrhythmias (Lown and Wolf, 1971). The precise nature and relative importance of the factors precipitating transient electrical instability of the heart, in often symptomless patients with coronary artery disease, is unknown. It is generally believed that catecholamines play an important part in precipitating ventricular fibrillation, and, since the cardiac effects of catecholamines are mediated mainly by activation of β-adrenoceptors, it is clear that the study of specific antagonists of the effect of catecholamines on these adrenoceptors (β blockers) in clinical and experimental myocardial ischaemia may clarify the role of catecholamines as a cause of sudden death.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahumada, G. G., Karlsberg, R. P., Jaffe, A. S., Ambos, H. D., Sobel, B. E. and Roberts, R. (1979). Reduction in early ventricular arrhythmias by acebutolol in patients with acute myocardial infarction. Br. Heart J., 41, 654–9
Andersen, M. P., Frederikson, J., Jurgensen, H. J., Pedersen, F., Bechsgoord, P., Hansen, D. A., Neilsen, B., Pedersen-Bjergaard, O. and Rasmussen, S. L. (1979). Effect of alprenolol on mortality among patients with definite and suspected acute myocardial infarction: preliminary results. Lancet, ii, 865–7
Baber, M. S., Evans, D. W., Howitt, G., Thomas, M. and Wilson, C. (1980). Two multicentre propranolol post-infarction trials in 84 hospitals in the United Kingdom, Italy and Yugoslavia. Br. Heart J., 44, 96–100
Barber, J. M., Boyle, D. C., Chaturvedi, H. C., Singh, N. and Walsh, M. J. (1976). Practolol in acute myocardial infarction. Acta. med. scand., 587, 213–6
Ceremuzynski, L., Staszewska-Barczak, J. and Herbaczynska-Cedro, K. (1969). Cardiac rhythm disturbances and the release of catecholamines after acute coronary occlusion in dogs. Cardiovasc. Res., 3, 190–7
Campbell, C. A. and Parratt, J. R. (1981). Which properties of beta-adrenoceptor blocking drugs are important in the prevention of early post-infarction dysrhythmias? Br. J. Pharmac., 74, 195–6P
Chamberlain, D. A. (1978). Beta-adrenergic blocking agents in prevention of sudden death. Adv. Cardiol., 25, 196–205
Corbalan, R., Verrier, R. L. and Lown, B. (1976). Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am. Heart J., 92, 223–30
Corr, P. D. and Gillis, R. A. (1975). Effect of autonomic neural influences on the cardiovascular changes induced by coronary occlusion. Am. Heart J., 89, 766–74
Corr, P. D. and Gillis, R. A. (1978). Autonomic neural influences on the dysrhythmias resulting from myocardial infarction. Circulation Res., 43, 1–9
Corr, P. D., Witkowski, F. X. and Sobel, B. E. (1978). Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat. J. clin. Invest., 61, 109–19
Ebert, P. A., Vanderbee, R. B., Allgood, R. J. and Sabiston, D. C. (1970). Effect of chronic denervation on arrhythmias after coronary artery ligation. Cardiovasc. Res., 4, 141–7
Erichsen, J. E. (1842). On the influence of the coronary circulation on the action of the heart. London med. Gaz., 30, 561–9
Evans, D. E., Peschka, M. T., Leigh, R. J. and Laffan, R. J. (1976). Antiarrhythmic action of nadolol, a beta-adrenergic receptor blocking agent. Eur. J. Pharmac., 35, 17–27
Fearon, R. E. (1967). Propranolol in the prevention of ventricular fibrillation due to experimental coronary artery occlusion. Am. J. Cardiol., 20, 222–8
Fitzgerald, J. D. (1969). Perspectives in adrenergic beta-receptor blockade. Clin. Pharmac. Ther., 10, 292–306
Fitzgerald, J. D. (1972). The role of beta-adrenergic blockade in acute myocardial ischaemia. In Effect of Acute Ischaemia on Myocardial Function (ed. M. F. Oliver, D. G. Julian and K. W. Donald), Churchill Livingstone, Edinburgh, pp. 321–51
Gillis, R. A. (1971). Role of the nervous system in the arrhythmias produced by coronary occlusion in the cat. Am. Heart J., 81, 677–84
Hampton, J. R. (1981). Presentation and analysis of the result of clinical trials in cardiovascular disease. Br. med. J., 282, 1371–73
Harris, A. S., Bochae, F. J. and Otero, H. (1975). Role of sympathetic excitation in generating arrhythmias in early and late phases of ectopic responses after coronary artery occlusion in dog heart. In Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. V (ed. A. Fleckenstein and N. S. Dhalla), University Park Press, Baltimore, pp. 315–21
Higginson, L., Ross, J., Franklin, D. and McKown, D. (1977). Reduction of myocardial infarct size by propranolol and morphine following coronary occlusion in dogs. Circulation, 55/56, Suppl. III, 111–49
Hoffman, B. F. and Singer, D. H. (1967). Appraisal of the effects of catecholamines on cardiac electrical activity. Ann. N. Y. Acad. Sci., 139, 914–39
Hope, R. R., Williams, D. O., El-Sheriff, N., Lazzara, R. and Scherlag, P. J. (1974). The efficacy of anti-arrhythmic agents during acute myocardial ischemia and the role of heart rate. Circulation, 50, 507–14
Jurgensen, H. J., Frederiksen, J., Hansen, D. A. and Padersen-Bjergaard, O. (1981). Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol. Br. Heart J., 45, 583–8
Kane, K. A., McDonald, F. M. and Parratt, J. R. (1979). Coronary artery ligation in anaesthetised rats as a model for the assessment of antidysrhythmic activity; the effects of lignocaine, propranolol and Org. 6001. Br. J. Pharmac., 66, 463–4P
Kaumann, A. J. and Aramendia, P. (1968). Prevention of ventricular fibrillation induced by coronary ligation. J. Pharmac. exp. Ther., 164, 326–32
Kelliher, G. J., Widmar, C. and Roberts, J. (1975). Influence of adrenal medulla on cardiac rhythm disturbances following acute coronary artery occlusion. In Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. 11 (ed. P. E. Roy and E. Rona), University Park Press, Baltimore, pp. 387–400
Kenedi, I. and Losonci, A. (1973). Effect of beta adrenergic blockade on the arrhythmias following coronary artery ligation in the rat. Acta physiol. hung., 44, 247–57
Khan, M. I., Hamilton, J. T. and Manning, G. W. (1972). Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs. Am. J. Cardiol., 30, 832–7
Kupersmith, J., Schiang, H., Litwak, R. S. and Herman, M. V. (1976). Electrophysiological and anti-arrhythmic effects of propranolol in canine acute myocardial ischaemia. Circulation Res., 38, 302–7
Lancet (1981). Beta blockers after myocardial infarction. Lancet, i, 873–4
Lown, B. and Wolf, M. (1971). Approaches to sudden death from coronary heart disease. Circulation, 44, 130–42
Lown, B., Verrier, R. L. and Rabinowitz, S. H. (1977). Neural and psychological mechanisms and the problem of sudden death. Am. J. Cardiol., 39, 890–902
Lubbe, W. F., Podzuweit, T., Daries, P. S. and Opie, L. H. (1978). The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart. J. clin. Invest., 58, 1260–9
Maling, H. M. and Moran, N. C. (1957). Ventricular arrhythmias induced by sympathomimetic amines in anaesthetised dogs following coronary artery occlusion. Circulation Res., 5, 409–13
Matta, R. J., Lawler, J. E. and Lown, B. (1976). Ventricular electrical instability in the conscious dog. Effects of psychological stress and beta adrenergic blockade. Am. J. Cardiol., 38, 594–8
Menken, U., Wiegard, V., Bucher, P. and Meesmann, W. (1979). Prophylaxis of ventricular fibrillation after experimental coronary occlusion by chronic betaadrenoceptor blockade. Cardiovasc. Res., 13, 588–94
Mitchell, J. R. A. (1981). Timolol after myocardial infarction: an answer or a new set of questions? Br. med. J., 282, 1566–70
Morris, J. J., Wohlegmuth, S., Jackson, D., Whalen, R. E. and McIntosh, H. D. (1967). Quinidine, propranolol and polarising solution in the treatment of experimental myocardial infarction. Clin. Res., 15, 57
Muller, C. A. and Opie, L. H. (1980). Cardio-selective versus non-selective beta-adrenoceptor antagonism and the incidence of arrhythmias in experimental myocardial infarction. J. molec. cell. Cardiol., 12, Suppl. 1, 1
Multicentre International Study (1977). Supplementary report: reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Br. med. J., ii, 419–21
Norwegian Multicenter Study Group (1981). Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New Engl. J. Med., 304, 801–7
Parratt, J. R., Campbell, C. and Fagbemi, O. (1981). Catecholamines and early post-infarction arrhythmias: the effects of α and β-adrenoceptor blockade. In Catecholamines and the Heart, Springer Verlag, Heidelberg, pp. 269–84
Pearle, D. L., Williford, D. and Gillis, R. A. (1978). Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion. Am. J. Cardiol., 42, 960–4
Pentecost, B. L. and Austen, W. O. (1966). Beta adrenergic blockade in experimental myocardial infarction. Am. Heart J., 72, 790–6
Peter, T., Heng, M. K., Singh, B. N., Ambler, P., Nisbet, H., Elliot, R. and Norris, R. M. (1978). Failure of high doses of propranolol to reduce experimental and myocardial ischemic damage. Circulation, 57, 534–40
Proger, S. and Naimi, L. (1966). Propranolol in myocardial infarction. Lancet, ii, 1465–6
Reynolds, R. D., Calzadilla, S. V. and Lee, R. J. (1978). Spontaneous heart rate, propranolol and ischaemia induced ventricular fibrillation in the dog. Cardiovasc. Res., 12, 653–8
Reimer, K. A., Rasmussen, N. M. and Jennings, R. B. (1973). Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circulation Res., 33, 653–8
Richardson, J. A. (1963). Circulating levels of catecholamines in acute myocardial infarction and angina pectoris. Progr. cardiovasc. Dis., 6, 56–62
Rosenfeld, J., Rosen, M. R. and Hoffman, B. F. (1978). Pharmacologic and behavioural effects on arrhythmias that immediately follow abrupt coronary occlusion: a canine model of sudden death. Am. J. Cardiol., 41, 1075–82
Rossi, P. R. F., Yus, S., Ramsdale, D., Peto, R., Furze, L., Bennet, D., Bray, C. and Sleight, P. (1982). Early intravenous beta blockade decreases ventricular arrhythmias in acute myocardial infarction. In press
Schwartz, P. J., Snebold, N. G. and Brown, A. M. (1976). Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am. J. Cardiol., 37, 1034–40
Sethi, V., Haider, B., Ahmed, S. S., Oldewurtel, H. A. and Regan, T. J. (1973). Influence of beta blockade and chemical sympathectomy on myocardial function and arrhythmias in acute ischaemia. Cardiovasc. Res., 7, 740–7
Sheridan, D. J., Penkoske, P. A., Sobel, B. E. and Corr, P. D. (1980). Alpha adrenergic contributions to dysrhythmia during myocardial ischaemia and reperfusion in cats. J. clin. Invest., 65, 161–71
Shuster, D. P., Lucchesi, B. R., Nobel, N. L., Mimnaugh, N. M., Counsell, R. E. and Kniffen, F. J. (1973). The anti-arrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol. J. Pharmac. exp. Ther., 184, 213–27
Siegmund, W., Leprán, I. and Szekeres, L. (1979). Effect of prolonged beta blocking treatment alone and in combination with parasympatholytic on early arrhythmias arising from sudden coronary occlusion in conscious rats. Acta physiol. hung., 53, 209
Skinner, J. E., Lie, J. T. and Entman, M. L. (1975). Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig: the effects of psychological stress and beta adrenergic blockade. Circulation, 51, 656–67
Snow, P. J. D. (1965). The effect of propranolol in myocardial infarction. Lancet, ii, 551–3
Sommers, H. L. (1966). The effect of reserpine and propranolol on spontaneous ventricular fibrillation and myocardial necrosis following transient coronary artery occlusion. Fedn Proc. Fedn Am. Socs exp. Biol., 25, 666
Staszewska-Barczak, J. and Ceremuzynski, L. (1968). The continuous estimation of catecholamine release in the early stages of myocardial infarction in the dog. Clin. Sci., 34, 531–9
Stephen, K. and Meesmann, W. (1974). Beenflusseung der fruhen Arrhythmien nach akuten Koronarverschluss durch Beta-Blockade mit Practolol. Z. Kardiol., 7, 603–11
Szekeres, L. (1978). Theoretical considerations concerning drug treatment of dysrhythmias due to coronary insufficiency. Adv. Pharmac. Ther., 6, 257–69
Vatner, S. F., Baig, H., Manders, W. R., Ochs, H. and Pagini, M. (1977). Effects of propranolol on regional myocardial function, electrograms and blood flow in conscious dogs with myocardial ischaemia. J. clin. Invest., 60, 353–60
Verrier, R. L., Calvert, A. and Lown, B. (1975). Effect of posterior hypothalmic stimulation on ventricular fibrillation threshold. Am. J. Physiol., 228, 923–7
Vedin, J. A. and Wilhelmsson, C. C. (1979). A review of current beta blocker trials in the world. Heart Bull., 10, 180–2
Wilcox, R. G., Roland, J. M., Banks, D. C., Hampton, J. R. and Mitchell, J. R. A. (1980). Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br. med. J., 280, 885–8
Wilhelmsson, C. C., Vedin, J. A., Wilhelmsen, L., Tibblin, G. and Werko, L. (1974). Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet, ii, 1158–60
Addendum References
Co-operative Trial (1981). The beta blocker heart attack trial. J. Am. med. Assoc., 246, 2073–4
Hampton, J. R. (1981). The use of beta blockers for the reduction of mortality after myocardial infarction. Eur. Heart J., 2, 259–68
Hansteen, V., Moinichen, E., Lorensten, E., Andersen, A., Strom, O., Soiland, K., Dyrbekk, D., Refsum, A.-M., Tromsdal, A., Knudsen, K., Eika, C., Bakken, J., Smith, P. and Hoff, P. I. (1982). One year’s treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br. med. J., 284, 155–60
Hjalmarson, A., Herlitz, J., Malek, I., Ryden, L., Vedin, A., Waldenstrom, A., Wedel, H., Elmfeldt, D., Holmberg, S., Nyberg, G., Swedberg, K., Waagstein, F., Waldenstrom, J., Wilhelmsen, L. and Wilhelmsson, C. (1981). Effect on mortality of metoprolol in acute myocardial infarction. Lancet, ii, 823–7
Editor information
Editors and Affiliations
Copyright information
© 1982 The contributors
About this chapter
Cite this chapter
Fitzgerald, J.D. (1982). The Effects of β-Adrenoceptor Blocking Drugs on Early Arrhythmias in Experimental and Clinical Myocardial Ischaemia. In: Parratt, J.R. (eds) Early Arrhythmias Resulting from Myocardial Ischaemia. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06260-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-349-06260-7_16
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-06262-1
Online ISBN: 978-1-349-06260-7
eBook Packages: MedicineMedicine (R0)